S
STADA
STADA Arzneimittel AG - stada.com
About STADA
STADA is a global pharmaceutical company that operates in the consumer healthcare, generics, and specialty pharma markets. The company serves a diverse range of clients including healthcare professionals, pharmacies, and consumers. STADA's business model is built on a three-pillar strategy: consumer healthcare products, generics, and specialty pharmaceuticals. This diversified approach allows the company to generate revenue through the sale of over-the-counter (OTC) products, prescription medications, and specialized treatments. In the financial year 2023, STADA achieved group sales of EUR 3,734.8 million and reported earnings before interest, taxes, depreciation, and amortization (EBITDA) of EUR 802 million. With a workforce of 11,466 employees worldwide, STADA continues to focus on its mission of bringing health to society. The company has a long history dating back to 1895 and has consistently expanded its portfolio through strategic acquisitions and partnerships. Recent activities include a 60% investment in the Italian New Pharmajani SpA and the acquisition of brand products from redinomedica AG for the German OTC market. STADA is committed to transparency and compliance, adhering to the Medicines for Europe Code of Conduct and other regulatory standards.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2006
- Employees
- 6,631
- Open positions
- 46
- Dealroom signal
- 41.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Human Resources, Risk Management, Real Estate, Biotechnology
- Business model
- Marketplace & ecommerce
- Client focus
- B2B
- Investment activity
- 3 companies, latest Jun 2015
- Capital deployed
- —
- Preferred round
- ACQUISITION
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| BUYOUT✓Exit | Sep 2025 | $11B | $11B | CapVest | ↗ |
| BUYOUTExit | Aug 2017 | — | — | Bain Capital · Cinven · CPP Investments | ↗ |
Growth signals
Latest recorded traffic for STADA is 68K monthly website visits, up 277.8% over the last three months. STADA's team grew 21.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Thornton & RossHuddersfield, United KingdomWelcome To Thornton & Ross
$292Mvaluation
STADA in the Moulins ecosystem
The STADA office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Bain Capital
Cinven
CPP Investments
CapVest
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about STADA on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See STADA’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








